Playlist


Turkmenistan is preparing for a vibrant series of celebrations and official ceremonies scheduled throughout the month of May. According to the government's approved plan, the upcoming month will be marked by several national holidays and the opening of new social and infrastructure projects. These events are designed to reflect the country's socio-economic progress and its commitment to honoring historical milestones and cultural identity.
The May agenda features prominent dates such as the Day of the Constitution and the State Flag, Victory Day, Ashgabat City Day, and the Turkmen Carpet Festival. Celebration plans include high-level conferences, cultural exhibitions, and gala concerts across the nation. A significant highlight of the month will be the official commissioning of various residential and public buildings, showcasing the ongoing urban development initiatives led by the state.
The cultural program is equally diverse, featuring international opera days organized by TÜRKSOY and special performances dedicated to the 110th anniversary of the renowned composer Veli Muhadov. Furthermore, the final stages of national folk music competitions will take place in several provinces and the capital, highlighting the country's rich artistic traditions. These activities aim to foster international cultural exchange and promote local talent.
Presidential directives have emphasized the need for meticulous preparation to ensure all events are conducted at a high organizational standard. As the country moves toward its 35th anniversary of independence, the May celebrations serve as a key component of the broader national development strategy. The scheduled festivities are expected to strengthen social cohesion and provide a platform for showcasing Turkmenistan’s modern achievements to the international community.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.